Home | Medical-Newswire.Com:
(Medical-NewsWire.com, November 14, 2017 ) Breast Biopsy Market was worth USD 436.4 million in 2016 and estimated to be growing at a CAGR of 10.8%, to reach USD 728.75 million by 2021.
Browse details of 170 pages research report on Breast Biopsy Market @ http://www.marketdataforecast.com/market-reports/breast-biopsy-market-4258/
Breast biopsy is a test performed to remove tissue or fluid from a diseased area of the patientís body, while the removed sample is further examined to check the presence of breast cancer. There are different types of biopsy procedures depending on the product, such as vacuum assisted biopsy (VAB), core needle biopsy (CNB), and fine needle aspiration biopsy (FNAB), recommended by the doctor based on the location, size, and other characteristics of the breast abnormality.
Increase in incidence of breast cancer in women especially around the age of 40 and growth in awareness regarding breast cancer screening programs drive the market growth. Emergence of technologically advanced and minimally invasive breast biopsy devices are expected to provide opportunities in this untapped market. The restraints in this market include high cost of procedure and demand skewed towards specific gender and middle age to elderly age group, eliminating a major chunk of the population segment. The risk of infection due to improper care of breast biopsy cuts and wounds and uncertain regulatory guidelines for medical devices are likely to limit the growth of the market.
Avail Sample Market Brochure of the report for more information, Get a Copy @ http://www.marketdataforecast.com/market-reports/breast-biopsy-market-4258/request-sample
Breast Biopsy Market is broadly categorized into product, type and guidance. By product the market is segmented into Biopsy needles, guidance systems, biopsy tables, localization wires and others. By type the market is classified into Needle breast biopsy and open surgical breast biopsy. Vacuum assisted biopsy accounts for a major portion of the revenue. By guidance the market is analysed under Mammography-Guided Stereotactic Breast Biopsy, Ultrasound-Guided Breast Biopsy , MRI-Guided Breast Biopsy , other techniques. The ultrasound segment is expected to be the fastest growing segment. On the basis of geography, the market is analysed under various regions namely North America, Europe, Asia-Pacific and Rest of the World. The Breast Biopsy market was dominated by North America followed by Europe. Asia Pacific is expected to grow at the highest CAGR.
The list of key players included in the report include Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC., Ethicon Endo Surgery (Johnson & Johnson), Intact Medical Corporation, and Galini SRL.
Inquiry before buying @ http://www.marketdataforecast.com/market-reports/breast-biopsy-market-4258/inquire
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626; Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
Market Data Forecast